161 related articles for article (PubMed ID: 36631800)
21. Upregulated Vav2 in gastric cancer tissues promotes tumor invasion and metastasis.
Tan BB; Li Y; Fan LQ; Zhao Q; Liu QW; Liu Y; Wang D; Jia N
Tumour Biol; 2017 May; 39(5):1010428317698392. PubMed ID: 28459214
[TBL] [Abstract][Full Text] [Related]
22. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
Yao H; Hu J; Shao Y; Shah Q; Zheng S
Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
[TBL] [Abstract][Full Text] [Related]
24. AFAP1L1, a novel associating partner with vinculin, modulates cellular morphology and motility, and promotes the progression of colorectal cancers.
Takahashi R; Nagayama S; Furu M; Kajita Y; Jin Y; Kato T; Imoto S; Sakai Y; Toguchida J
Cancer Med; 2014 Aug; 3(4):759-74. PubMed ID: 24723436
[TBL] [Abstract][Full Text] [Related]
25. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
[TBL] [Abstract][Full Text] [Related]
26. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
Chen Y; Liu J; Wang W; Xiang L; Wang J; Liu S; Zhou H; Guo Z
Oncol Rep; 2018 Apr; 39(4):1693-1701. PubMed ID: 29484423
[TBL] [Abstract][Full Text] [Related]
27. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
Wang F; Ruan L; Yang J; Zhao Q; Wei W
Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
[TBL] [Abstract][Full Text] [Related]
28. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
29. Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas.
Furu M; Kajita Y; Nagayama S; Ishibe T; Shima Y; Nishijo K; Uejima D; Takahashi R; Aoyama T; Nakayama T; Nakamura T; Nakashima Y; Ikegawa M; Imoto S; Katagiri T; Nakamura Y; Toguchida J
Oncogene; 2011 Sep; 30(38):4015-25. PubMed ID: 21516130
[TBL] [Abstract][Full Text] [Related]
30. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
31. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
33. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
34. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
35. SNHG3 silencing suppresses the malignant development of triple-negative breast cancer cells by regulating miRNA-326/integrin α5 axis and inactivating Vav2/Rac1 signaling pathway.
Wang P; Liu GZ; Wang JF; Du YY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5481-5492. PubMed ID: 32495883
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.
Huo FC; Zhu WT; Liu X; Zhou Y; Zhang LS; Mou J
Invest New Drugs; 2021 Apr; 39(2):304-316. PubMed ID: 32949323
[TBL] [Abstract][Full Text] [Related]
37. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
Zhang X; Wu J
Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
[TBL] [Abstract][Full Text] [Related]
38. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.
Tian S; Peng P; Li J; Deng H; Zhan N; Zeng Z; Dong W
Aging (Albany NY); 2020 Feb; 12(4):3574-3593. PubMed ID: 32091407
[TBL] [Abstract][Full Text] [Related]
39. RPS15A promotes gastric cancer progression via activation of the Akt/IKK-β/NF-κB signalling pathway.
Liu C; He X; Liu X; Yu J; Zhang M; Yu F; Wang Y
J Cell Mol Med; 2019 Mar; 23(3):2207-2218. PubMed ID: 30661291
[TBL] [Abstract][Full Text] [Related]
40. Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer.
Nishimura S; Yamamoto Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Kasashima H; Ohira M; Maeda K; Yashiro M
Gastric Cancer; 2022 Sep; 25(5):850-861. PubMed ID: 35705840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
